Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care. 2004;42:200–209.PubMedCrossRef
World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization; 2003.
National Council on Patient Information and Education. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Bethesda, MD; 2007.
Osterberg L, Blaschke T.
Adherence to medication. N Engl J Med. 2005;353:487–97.PubMedCrossRef
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW.
Patient adherence and medial treatment outcomes: A meta-analysis. Med Care. 2002;40:794–811.PubMedCrossRef
Wu JR, Moser DK, Chung ML, Lennie TA.
Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14:203–10.PubMedCrossRef
Hiligsmann M, Rabenda V, Bruyere O, Reginster JY. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96:170–7.
Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY. Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcif Tissue Int. 2010;86:202–10.
Davis KL, Edin HM, Allen JK. Prevalence and cost of medication nonadherence in Parkinson's disease: Evidence from administrative claims data. Mov Disord. 2010;25:474–80.
Kane SV, Chao J, Mulani PM.
Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients. Adv Ther. 2009;26:936–46.PubMedCrossRef
Heisler M, Choi H, Rosen AB, et al.
Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: A longitudinal analysis. Med Care. 2010;48:87–94.PubMed
Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR.
Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9:2597–606.PubMedCrossRef
Breitscheidel L, Stamenitis S, Dippel FW, Schoffski O. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: A review paper. J Med Econ. 2010;13:8-15.
McGinnis BD, Olson KL, Delate TM, Stolcpart RS.
Statin adherence and mortality in patients enrolled in a secondary prevention program. Am J Manag Care. 2009;15:689–95.PubMed
Rasmussen JN, Chong A, Alter DA.
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–86.PubMedCrossRef
Ho PM, Magid DJ, Masoudi FA, McClure DL, Rumsfeld JS.
Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48.PubMedCrossRef
Kripalani S, Yao X, Haynes RB.
Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Arch Intern Med. 2007;167:540–50.PubMedCrossRef
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 CD000011.
DiMatteo MR, Haskard KB, Williams SL.
Health beliefs, disease severity, and patient adherence: A meta-analysis. Med Care. 2007;45:521–8.PubMedCrossRef
DiMatteo MR. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Counsel Special Issue: Educating and Counseling Children about Physical Health. 2004;55:339–344.
Zolnierek KB, Dimatteo MR.
Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009;47:826–34.PubMedCrossRef
Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S.
Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66:657–64.PubMedCrossRef
Manning WG Jr, Wells KB.
The effects of psychological distress and psychological well-being on use of medical services. Medical Care. 1992;30:541–53.PubMedCrossRef
Piette JD, Richardson C, Valenstein M.
Addressing the needs of patients with multiple chronic illnesses: The case of diabetes and depression. Am J Manag Care. 2004;10:152–62.PubMed
DiMatteo MR, Lepper HS, Croghan TW.
Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.PubMedCrossRef
Gonzalez JS, Peyrot M, McCarl LA, et al.
Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care. 2008;31:2398–403.PubMedCrossRef
Rosenthal R. Meta-analytic procedures for social research. Applied social research methods series. London: Sage; 1984.
Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB.
The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 2004;42:649–52.PubMedCrossRef
Andrade SE, Kahler KH, Frech F, Chan KA.
Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565–74. discussion 575-7.PubMedCrossRef
The adherence estimator: A brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25:215–38.PubMedCrossRef
Janson SL, Earnest G, Wong KP, Blanc PD.
Predictors of asthma medication nonadherence. Heart Lung. 2008;37:211–8.PubMedCrossRef
Predictors of medication adherence in the elderly. Clin Ther. 1998;20:764–71.PubMedCrossRef
Senior V, Marteau TM, Weinman J.
Genetic Risk Assessment for FHTSG. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: The role of illness perceptions. Cardiovasc Drugs Ther. 2004;18:475–81.PubMedCrossRef
Culture and depression. N Engl J Med. 2004;351:951–3.PubMedCrossRef
Paterson DL, Swindells S, Mohr J, et al.
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMed
Mannheimer S, Friedland G, Matts J, Child C, Chesney M.
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34:1115–21.PubMedCrossRef
Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego, CA: Academic Press; 1985:xxii–369.
Peterson RA, Brown SP.
On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005;90:175–181.PubMedCrossRef
Friedman DS, Okeke CO, Jampel HD, et al. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology. 2009; 116:1097-105.
Ross SM. Simulation. 4th ed. Amsterdam: Elsevier Academic Press; 2006:xiii–298 s.
Pearson K. Mathematical contributions to the theory of evolution. Vii, viii. Proceedings of the Royal Society. 1900; LXVI:140-164, 241-244.
Rosenthal R, Rosnow RL, Rubin DB. Contrasts and effect sizes in behavioral research: A correlational approach. New York, NY US: Cambridge University Press; 2000.
Berkey CS, Hoaglin DC, Mosteller F, Colditz GA.
A random-effects regression model for meta-analysis. Stat Med. 1995;14:395–411.PubMedCrossRef
StataCorp. Stata statistical software. In: Release 10. College Station. TX: StataCorp LP; 2007.
Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D.
Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum. 2002;47:630–8.PubMedCrossRef
Kronish IM, Rieckmann N, Halm EA, et al.
Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med. 2006;21:1178–83.PubMedCrossRef
Morgado A, Smith M, Lecrubier Y, Widlocher D.
Depressed subjects unwittingly overreport poor social adjustment which they reappraise when recovered. J Nerv Ment Dis. 1991;179:614–9.PubMedCrossRef
Steiner JF, Gardner EM.
Assessing medication adherence from pharmacy records. Pharmacoepidemiology and Drug Safety. 2006;15:575–7.CrossRef
Kessler RC, Berglund P, Demler O, et al.
The epidemiology of major depressive disorder: Results from the national comorbidity survey replication (ncs-r). JAMA. 2003;289:3095–105.PubMedCrossRef
Hasin DS, Goodwin RD, Stinson FS, Grant BF.
Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatr. 2005;62:1097–106.PubMedCrossRef
Depression in the elderly. Lancet. 2005;365:1961–70.PubMedCrossRef
Katon WJ, Rutter C, Simon G, et al.
The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668–72.PubMedCrossRef
Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, de Jonge P.
Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol. 2010;56:838–44.PubMedCrossRef
Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC.
Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care. 2009;15:e22–33.PubMed
Claxton AJ, Cramer J, Pierce C.
A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–310.PubMedCrossRef
Goldman DP, Joyce GF, Zheng Y.
Prescription drug cost sharing: Associations with medication and medical utilization and spending and health. JAMA. 2007;298:61–9.PubMedCrossRef
Gellad WF, Grenard JL, McGlynn EA. A review of barriers to medication adherence. In: A framework for driving policy options. Santa Monica, CA: RAND Corp; 2009.
Chapman RH, Ferrufino CP, Kowal SL, Classi P, Roberts CS.
The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*. Int J Clin Pract. 2010;64:169–81.PubMedCrossRef
McDonald HP, Garg AX, Haynes RB.
Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA. 2002;288:2868–79.PubMedCrossRef
Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R.
Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Educ Couns. 2002;46:93–108.PubMedCrossRef
Malta M, Magnanini MM, Strathdee SA, Bastos FI.
Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS Behav. 2010;14:731–47.PubMedCrossRef
Cruess DG, Localio AR, Platt AB, et al. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med. 2010; 17:33–42.
Apter AJ, Boston RC, George M, et al.
Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white. J Allergy Clin Immunol. 2003;111:1219–26.PubMedCrossRef
Smith A, Krishnan JA, Bilderback A, Riekert KA, Rand CS, Bartlett SJ.
Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest. 2006;130:1034–8.PubMedCrossRef
Gehi A, Haas D, Pipkin S, Whooley MA.
Depression and medication adherence in outpatients with coronary heart disease: Findings from the heart and soul study. Arch Intern Med. 2005;165:2508–13.PubMedCrossRef
Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS.
Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med. 1998;24:35–9.PubMedCrossRef
Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE.
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818–23.PubMedCrossRef
Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: The role of disease and medication beliefs. J Behav Med. 2009;32:278–84.
Gonzalez JS, Safren SA, Delahanty LM, et al.
Symptoms of depression prospectively predict poorer self-care in patients with type 2 diabetes. Diabet Med. 2008;25:1102–7.PubMedCrossRef
Chao J, Nau DP, Aikens JE, Taylor SD.
The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm. 2005;1:508–25.PubMedCrossRef
Hill-Briggs F, Gary TL, Bone LR, Hill MN, Levine DM, Brancati FL.
Medication adherence and diabetes control in urban african americans with type 2 diabetes. Health Psychol. 2005;24:349–57.PubMedCrossRef
Kalsekar ID, Madhavan SS, Amonkar MM, et al.
Depression in patients with type 2 diabetes: Impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006;40:605–11.PubMedCrossRef
Kilbourne AM, Reynolds CF 3rd, Good CB, Sereika SM, Justice AC, Fine MJ.
How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13:202–10.PubMed
Wu JR, Moser DK, Chung ML, Lennie TA.
Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail. 2008;14:603–14.PubMedCrossRef
Cukor D, Rosenthal DS, Jindal RM, Brown CD, Kimmel PL. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int. 2009; 75:1223–9.
Schoenthaler A, Chaplin WF, Allegrante JP, et al.
Provider communication effects medication adherence in hypertensive african americans. Patient Educ Couns. 2009;75:185–91.PubMedCrossRef
Schoenthaler A, Ogedegbe G, Allegrante JP.
Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive african americans. Health Educ Behav. 2009;36:127–37.PubMedCrossRef
Chapman RH, Benner JS, Petrilla AA, et al.
Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147–52.PubMedCrossRef
Kim EY, Han HR, Jeong S, et al.
Does knowledge matter?: Intentional medication nonadherence among middle-aged korean americans with high blood pressure. J Cardiovasc Nurs. 2007;22:397–404.PubMed
Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD.
Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483–92.PubMedCrossRef
Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J.
Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504–11.PubMedCrossRef
Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J.
Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27:117–24.PubMedCrossRef
Insel K, Morrow D, Brewer B, Figueredo A.
Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci. 2006;61:P102–P107.PubMed
Van Houtven CH, Voils CI, Oddone EZ, et al.
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med. 2005;20:578–83.PubMedCrossRef
Davis DP, Jandrisevits MD, Iles S, Weber TR, Gallo LC. Demographic, socioeconomic, and psychological factors related to medication non-adherence among emergency department patients. J Emerg Med. Epub 2009 May 21.
Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K.
Factors associated with medication refill adherence in cardiovascular-related diseases: A focus on health literacy. J Gen Intern Med. 2006;21:1215–21.PubMedCrossRef